Orchard Therapeutics Plc ADR (ORTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,469 | 38,273 | 61,487 | 68,424 | 80,751 |
| Marketable Securities | 101,944 | 112,468 | 84,828 | 75,326 | 65,803 |
| Receivables | 14,421 | 18,072 | 6,075 | 14,409 | 15,708 |
| Inventories | 6,638 | 6,937 | N/A | 3,400 | N/A |
| TOTAL | $153,923 | $181,290 | $166,200 | $168,145 | $179,253 |
| Non-Current Assets | |||||
| PPE Net | 7,131 | 7,808 | 8,149 | 8,138 | 7,804 |
| Intangibles | 3,321 | 3,474 | 3,518 | 3,560 | 3,487 |
| Other Non-Current Assets | 37,891 | 39,730 | 39,150 | 39,064 | 43,506 |
| TOTAL | $48,343 | $51,012 | $50,817 | $50,762 | $54,797 |
| Total Assets | $202,266 | $232,302 | $217,017 | $218,907 | $234,050 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,661 | 6,950 | 8,772 | 9,318 | 6,518 |
| Accrued Expenses | 29,995 | 33,786 | 27,984 | 34,437 | 28,267 |
| TOTAL | $49,375 | $57,517 | $53,286 | $60,567 | $50,265 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,162 | 18,440 | 20,717 | 22,991 | 25,265 |
| Deferred Revenues | 742 | 752 | 634 | 959 | 1,375 |
| Other Non-Current Liabilities | 46,126 | 36,479 | 30,580 | 26,770 | 25,716 |
| TOTAL | $72,633 | $65,738 | $62,076 | $60,076 | $60,082 |
| Total Liabilities | $122,008 | $123,255 | $115,362 | $120,643 | $110,347 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,761 | 22,723 | 18,426 | 183,985 | 12,669 |
| Common Shares | 29,463 | 29,456 | 23,871 | 16,419 | 16,370 |
| Retained earnings | -965,922 | -930,603 | -918,296 | -900,884 | -893,001 |
| Other shareholders' equity | 22,609 | 18,552 | 20,361 | 26,018 | 47,573 |
| TOTAL | $80,258 | $109,047 | $101,655 | $98,264 | $123,703 |
| Total Liabilities And Equity | $202,266 | $232,302 | $217,017 | $218,907 | $234,050 |